The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer
Author:
K. -L. Garm Spindler,N. Pallisgaard,A.A. Rasmussen,J. Lindebjerg,R.F. Andersen,D. Crüger,A. Jakobsen
Publication:
Annals of Oncology
Copyright © 2009 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.